Search Ontology:
ChEBI
zanamivir
- Term ID
- CHEBI:50663
- Synonyms
-
- (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
- 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid
- 4-guanidino-Neu5Ac2en
- 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
- 5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid
- 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid
- GANA
- Relenza
- ZANAMIVIR
- Definition
- References
-
- beilstein:7083099
- cas:139110-80-8
- drugbank:DB00558
- drugcentral:2859
- kegg.compound:C08095
- kegg.drug:D00902
- patent:US5360817
- patent:WO9116320
- pdb-ccd:ZMR
- wikipedia.en:Zanamivir
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from zanamivir
Phenotype where environments contain zanamivir
Phenotype modified by environments containing zanamivir
Phenotype affecting zanamivir
Human Disease Model